Terms ending in 2033
Every in-force patent on Biotissue Holdings Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,526,770 | Methods of Modulating Bone Remodeling In force · High confidence | Blue Tech Industries, Inc. | In force | High confidence | |
| US 8,940,294 | Methods of Isolating and Culturing Stem Cells In force · High confidence | Biotissue Holdings Inc. | In force | High confidence | |
| US 9,682,044 | Methods of Processing Fetal Support Tissues, Fetal Support Tissue Powder Products, and Uses Thereof In force · High confidence | Biotissue Holdings Inc. | In force | High confidence | |
| US 10,040,821 | Compositions Containing HC-HA/PTX3 Complexes and Methods of Use Thereof In force · High confidence | Biotissue Holdings Inc. | In force | High confidence | |
| US 10,253,065 | Compositions Containing HC-HA/PTX3 Complexes and Methods of Use Thereof In force · High confidence | Biotissue Holdings Inc. | In force | High confidence | |
| US 10,717,763 | Compositions Containing HC-HA/PTX3 Complexes and Methods of Use Thereof In force · High confidence | Biotissue Holdings Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Biotissue Holdings Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.